147 Review of patients with metastatic and locally advanced NSCLC who receive 2 years of palliative pembrolizumab with or without chemotherapy

Lung Cancer 2026

View at publisher
Authors: Mick Button, Sally Fouda, Po Chung Chan, Samantha Cox, Gwenllian Edwards, Sahar Iqbal, Ceri J. Powell, Paul H.S. Shaw, Sarah Walters, Tom Wilson
DOI: 10.1016/j.lungcan.2026.109096
Cited by: 0
References: 1

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Lung Cancer
Volume
212
Pages
109096–109096
Publication date
1 February 2026
Language
EN